Elanco Animal Health Net Income 2016-2026 | ELAN

Elanco Animal Health annual/quarterly net income history and growth rate from 2016 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Elanco Animal Health net income for the quarter ending June 30, 2026 was $54M, a 390.91% increase year-over-year.
  • Elanco Animal Health net income for the twelve months ending June 30, 2026 was $-0.199B, a 145.85% decline year-over-year.
  • Elanco Animal Health annual net income for 2025 was $-0.232B, a 168.64% decline from 2024.
  • Elanco Animal Health annual net income for 2024 was $0.338B, a 127.46% decline from 2023.
  • Elanco Animal Health annual net income for 2023 was $-1.231B, a 1478.21% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Elanco Animal Health Annual Net Income
(Millions of US $)
2025 $-232
2024 $338
2023 $-1,231
2022 $-78
2021 $-483
2020 $-574
2019 $68
2018 $87
2017 $-311
2016 $-48
2015 $-211
Elanco Animal Health Quarterly Net Income
(Millions of US $)
2026-06-30 $54
2026-03-31 $57
2025-12-31 $-276
2025-09-30 $-34
2025-06-30 $11
2025-03-31 $67
2024-12-31 $-8
2024-09-30 $364
2024-06-30 $-50
2024-03-31 $32
2023-12-31 $-141
2023-09-30 $-1,096
2023-06-30 $-97
2023-03-31 $103
2022-12-31 $-54
2022-09-30 $-65
2022-06-30 $-10
2022-03-31 $51
2021-12-31 $-108
2021-09-30 $-104
2021-06-30 $-210
2021-03-31 $-61
2020-12-31 $-337
2020-09-30 $-135
2020-06-30 $-53
2020-03-31 $-49
2019-12-31 $-9
2019-09-30 $10
2019-06-30 $36
2019-03-31 $32
2018-12-31 $16
2018-09-30 $60
2018-06-30 $-63
2018-03-31 $73
2017-09-30 $-21
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $11.491B $4.715B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Chemed (CHE) United States $6.620B 23.60
RadNet (RDNT) United States $6.069B 175.27
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
U.S Physical Therapy (USPH) United States $1.220B 32.19
Daxor (DXR) United States $0.065B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00